Literature DB >> 22349591

Interferon stimulated genes, CXCR4 and immune cell responses in peripheral blood mononuclear cells infected with bovine viral diarrhea virus.

C M Weiner1, N P Smirnova, B T Webb, H Van Campen, T R Hansen.   

Abstract

Non-cytopathic bovine viral diarrhea virus (ncpBVDV) induces immune responses mediated by chemokines and interferon (IFN) stimulated genes (ISGs). Cultured bovine peripheral blood mononuclear cells (PBMC) from ncpBVDV-naïve cattle were used herein to demonstrate that BVDV infection modulates chemokine receptor 4 (CXCR4), CXCL12, IFN-I, ISGs and selected immune cell marker (CD4, CD8, CD14) mRNAs, and that these acute responses to viral infection are reflected in PBMC cultured with serum from heifers carrying fetuses persistently infected (PI) with ncpBVDV. Infection of PBMC with ncpBVDV increased IFN-β, ISG15, RIG-I, CXCR4, CXCL12, and CD8 mRNA concentrations after 32 h. Culture of PBMC with uterine vein serum from acutely infected heifers, inoculated with ncpBVDV during early gestation to generate PI fetuses, also increased the concentration of CXCR4, RIG-I and ISG15 mRNAs. In vitro PBMC treatment with ncpBVDV or uterine vein serum from acutely infected pregnant heifers activates chemokine, ISG and immune cell responses.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22349591     DOI: 10.1016/j.rvsc.2012.01.011

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  2 in total

1.  Differential neutrophil gene expression in early bovine pregnancy.

Authors:  Keiichiro Kizaki; Ayumi Shichijo-Kizaki; Tadashi Furusawa; Toru Takahashi; Misa Hosoe; Kazuyoshi Hashizume
Journal:  Reprod Biol Endocrinol       Date:  2013-02-05       Impact factor: 5.211

2.  Potential evidence for biotype-specific chemokine profile following BVDV infection of bovine macrophages.

Authors:  Stephen Burr; Carole Thomas; Joe Brownlie; Victoria Offord; Tracey J Coffey; Dirk Werling
Journal:  Vet Immunol Immunopathol       Date:  2012-09-01       Impact factor: 2.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.